Given one of the important roles that cell hyperproliferation plays in vascular remodeling during the progression of group 1 PAH and group 3 PH,1 we sought to investigate the therapeutic implications of the cyclin D-CDK4 disulfide bond. Here, CDK4 is linked to pulmonary arterial hypertension.